Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=36081149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR043332(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Sciences IncfiledCriticalGilead Sciences Inc
Publication of AR043332A1publicationCriticalpatent/AR043332A1/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Combinaciones terapéuticas de [9-[R-2-[[(S)-1-(isopropoxicarbonil)etil]amino-fenoxifosfinil]metoxi]propil]adenina (GS-7340) y (2R, 5S, cis)-4-amino-5-fluoro-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1H)-pirimidin-2-ona (emtricitabina, (-)-cis FTC, Emtriva [marca]) y sus derivados fisiológicamente funcionales y opcionalmente un tercer agente antiviral. Las combinaciones pueden ser útiles en el tratamiento de infecciones de HIV, incluyendo infecciones con mutantes de HIV resistentes a inhibidores de nucleósido o de nucleósido. Composiciones farmacéuticas y formulaciones de dichas combinaciones de GS-7340 y emtricitabina, y sus derivados fisiológicamente funcionales, y métodos de uso terapéutico de esas composiciones y formulaciones.
ARP0401000882003-01-142004-01-14Composiciones y metodos para terapia antiviral
AR043332A1
(es)
composição farmacêutica, uso de uma composição de matéria, e, uso de uma combinação terapeuticamente eficaz de um oligonucleotìdeo anti-sentido de survivina e cloridrato de gemcitabina
Composiciones farmaceuticas que contienen 2-[6-(3-amino-pipenidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-primidin-1-il metil]-4-fluoro-benzonitrilo. uso. metodo de tratamiento, administracion semanal de inhibidores de la dipeptidilpeptidasa.
citrate, malonate and succinate salts of the HIV inhibitor ethyl N-[(S)({ [(2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl]oxy} methyl)phenoxyphosphinoyl]-L-alaninate